Table of Contents Table of Contents
Previous Page  2465 / 2894 Next Page
Information
Show Menu
Previous Page 2465 / 2894 Next Page
Page Background

14. Gentile R, Stevenson G, Dooley T, et al: Non-inva-

sive determination of time of ductal closure in

normal newborn infants. Pediatr Cardiol 1:177,

1979.

15. Hislop A, Beid L: Pulmonary arterial development

during childhood: Branching pattern and structure.

Thorax 28:129, 1973.

16. Waldman S, Krauss AN, Auld PAM: Baroreceptors

in preterm infants: Their relationship to maturity

and disease. Dev Med Child Neurol 21:714, 1979.

17. Daly MD, Angell-James JE, Elsner R: Role of caro-

tid-body chemoreceptors and their reflex interac-

tions in bradycardia and cardiac arrest. Lancet

1:764, 1979.

18. Penefsky ZJ: Perinatal development of cardiac con-

tractile mechanisms.

In

Gootman N, Gootman P

(eds): Perinatal Cardiovascular Function. New York,

Marcel Dekker, 1983, p 188.

19. Freed MA, Heymann MA, Lewis AB, et al: Prosta-

glandin E

1

in infants with ductus arteriosus–depen-

dent congenital heart disease. Circulation 64:899,

1981.

20. Crone RK: Acute circulatory failure in children.

Pediatr Clin North Am 27:525, 1980.

21. Carcillo JA, Fields AI: American College of Critical

Care Medicine Task Force Committee Members:

Clinical practice parameters for hemodynamic

support of pediatric and neonatal patients in septic

shock. Crit Care Med 30:1365, 2002.

22. Leung DY: New developments in Kawasaki disease.

Curr Opin Rheumatol 3:46, 1991.

23. Gersony WM: Diagnosis and management of Kawa-

saki disease. JAMA 265:2699, 1991.

24. Aretz HT, BillinghamME, Edwards WD, et al: Myo-

carditis: A histopathologic definition and classifica-

tion. Am J Cardiovasc Pathol 1:3, 1986.

25. Wagner MB, McCabe JB: A comparison of four

techniques to establish interosseous infusion.

Pediatr Emerg Care 4:87, 1988.

26. Cote C, Schwartz A, Jobes D, et al: Two approaches

to cannulation of the child’s internal jugular vein.

Anesthesiology 50:371, 1979.

27. Prince SR, Sullivan RL, Hackel A: Percutaneous

catheterization of the internal jugular vein in infants

and children. Anesthesiology 44:170, 1976.

28. Feltes TF, Pignatelli R, Kleinert S, Mariscalco MM:

Quantitated left ventricular systolic mechanics in

children with septic shock utilizing noninvasive

wall stress analysis. Crit Care Med 22:1647,

1994.

29. Cicek S, Demirkilic U, Kuralay E, et al: Transesopha-

geal echocardiography in cardiac surgical emergen-

cies. J Card Surg 10:236, 2007.

30. Thompson AE: Pulmonary artery catheterization in

children. New Horizons 5:244, 1997.

31. Pollack MM, Reed TD, Holbrook PR, et al: Bedside

pulmonary artery catheterization in pediatrics.

J Pediatr 96:274, 1980.

32. Dillon TR, Janos CC, Meyer RA, et al: Vasodilator

therapy for congestive heart failure. J Pediatr 96:623,

1980.

33. Outwater K, Treves ST, Lang P, et al: Renal and

hemodynamic effects of dopamine in infants

following cardiac surgery. J Clin Anesth 2:253,

1990.

34. Bhimji S, Godin DV, McNeill JH: Isoproterenol-

induced myocardial ischemia in the rabbit: Functional

and ultrastructureal alterations. Acta Anat 127:205,

1986.

35. Martinez AM, Padbury JF, Thio S: Dobutamine

pharmacokinetics and cardiovascular responses in

critically ill neonates. Pediatrics 89:47, 1992.

36. Perkin RM, Levin DL, Webb R, et al: Dobutamine:

A hemodynamic evaluation in children with shock.

J Pediatr 100:977, 1982.

37. Beloeil D, Mazoit JX, Benhamou D, et al: Norepine-

phrine kinetics and dynamics in septic shock and

trauma patients. Br J Anaesth 95:782, 2005.

38. Hoffman TM, Wernovsky G, Atz AM, et al: Efficacy

and safety of milrinone in preventing low cardiac

output syndrome in infants and children after

corrective surgery for congenital heart disease. Cir-

culation 107:996, 2003.

39. Barton P, Garcia J, Kovatli A, et al: Hemodynamic

effects of IV milrinone lactate in pediatric patients

with septic shock. Chest 109:1302, 1996.

40. Bailey JM, Miller BE, Lu W, et al: The pharmacoki-

netics of milrinone in pediatric patients after cardiac

surgery. Anesthesiology 90:1012, 1999.

41. Ramamoorthy C, Williams GD, Bratton SL, et al:

Pharmacodynamics of milrinone in children

following open heart surgery. Anesth Analg

82:SCA19, 1996.

42. Singh S: Digitalis toxicity in infancy and childhood.

Indian J Pediatr 55:27, 1988.

43. DropLJ,GeffenGA,O’KeffeDD

,etal:Relationbetween

ionized calcium concentration and ventricular pump

performance in the dog under hemodynamically con-

trolled conditions. Am J Cardiol 47:1041, 1981.

44. Beekman RN, Rocchini AP, Rosenthal A: Hemody-

namic effects of nitroprusside in infants with a large

ventricular septal defect. Circulation 64:553, 1981.

45. Rubin LJ, Peter RN: Oral hydralazine for primary

pulmonary hypertension. N Engl J Med 302:69,

1980.

46. Drummond WH, Gregory GA, Neymann MA, et al:

The independent effects of hyperventilation, tolazo-

line and dopamine on infants with persistent pul-

monary hypertension. J Pediatr 98:603, 1981.

47. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide

release accounts for the biological activity of endo-

thelium-derived releasing factors. Nature 325:524,

1987.

48. Roberts JD, Fineman JR, Morin FC, Shaul PW:

Inhaled nitric oxide and persistent pulmonary

hypertension of the newborn. N Engl J Med 336:605,

1997.

49. Zapol WM, Hurford WE: Inhaled nitric oxide in the

adult respiratory distress syndrome and other lung

diseases. New Horizons 4:638, 1993.

50. Kinsella JP, Abman SH: Recent developments in the

pathophysiology and treatment of persistent pul-

monary hypertension of the newborn. J Pediatr

126:853, 1995.

51. Camm AJ, Garratt CJ: Adenosine and supraventri-

cular tachycardia. N Engl J Med 326:1621, 1991.

52. Flynn PA, Engle MA, Ehlers KH: Cardiac issues in

the pediatric emergency room. Pediatr Clin North

Am 39:955, 1992.

53. Stapleton FB, Jones DP, Green RS: Acute renal

failure in neonates: Incidence, etiology and outcome.

Pediatr Nephrol 1:314, 1987.

54. Sinaiko AR: Pharmacologic management of child-

hood hypertension. Pediatr Clin North Am 409:195,

1993.

55. Newburger JW, Takahashi M, Beiser AS, et al: A

single intravenous infusion of gamma globulin as

compared with four infusions in the treatment of

acute Kawasaki syndrome. N Engl J Med 324:1633,

1991.

56. American Heart Association Committee on Rheu-

matic Fever, Endocarditis, and Kawasaki Disease:

Diagnostic guidelines for Kawasaki disease. Am J

Dis Child 144:1218, 1990.

57. Menahem S, Venables AW: Anomalous left coronary

artery from the pulmonary artery: A 15 year sample.

Br Heart J 58:378, 1987.

58. Clements IA, Nellenbogen J, Trahan H: Pulmonary

surfactant and evolution of the lungs. Science

69:603, 1970.

59. O’Rourke PP: Pulmonary hypertension of the

newborn: Medical treatment and extracorporeal

membrane oxygenation (ECMO).

In

Weir EK,

Archer SL, Reeves JT (eds): The Diagnosis and

Treatment of Pulmonary Hypertension. Mount

Kisco, NY, Futura, 1992, p 139.

60. Keens TG, Bryan AC, Levison H, et al: Developmen-

tal patterns of muscle fiber types in human ventila-

tory muscles. J Appl Physiol 44:909, 1978.

61. Fisher JT, Mortola JP, Smith JB, et al: Respiration in

newborns: Development of the control of breathing.

Am Rev Respir Dis 56:650, 1985.

62. Echenhoff J: Some anatomic considerations of the

infant larynx influencing endotracheal anesthesia.

Anesthesiology 12:401, 1951.

63. McNiece WL, Dierdorf SF: The pediatric airway.

Semin Pediatr Surg 13:152, 2004.

64. Wheeler M, Cote CJ, Todres DI: Pediatric airway.

In

Cote CJ, Todres ID, Goudsonzian, et al (eds): A

Practice of Anesthesia for Infants and Children. Phi-

ladelphia, WB Saunders, 2001, p 92.

65. Fine GF, Borland LN: The future of cuffed endotar-

cheal tubes. Paediatr Anaesth 14:38, 2004.

66. Dolfuss R, Milic-Emili J, Bates D: Regional ventila-

tion of the lung studied with boluses of (133)xenon.

Respir Physiol 2:234, 1967.

67. Rigatto H, Brady J, de la Torre Verduzco R: Chemo-

receptor reflexes in preterm infants: The effect of

gestational age and postnatal age on ventilatory res-

ponse to inhalation of 100% and 15% oxygen. Pedia-

trics 55:604, 1975.

68. O’Rourke PP: Assessment and monitoring of respi-

ratory function.

In

Fuhrman BP, Zimmerman JJ

(eds): Pediatric Critical Care. St Louis, CV Mosby,

1992, p 411.

69. Kitterman JA, Phibbs PH, Tooley WH: Catheteriza-

tion of umbilical vessels in newborn infants. Pediatr

Clin North Am 17:895, 1970.

70. Gardner RU, Schwartz R, Wong HC, et al: Percuta-

neous indwelling radial artery catheters for monito-

ring cardiovascular function: Prospective study of

the risk of thrombosis and infection. N Engl J Med

290:1227, 1974.

71. Stock MC: Non-invasive carbon dioxide monito-

ring. Crit Care Clin 4:522, 1988.

72. Brown M, Vender JS: Non-invasive oxygen monito-

ring. Crit Care Clin 4:499, 1988.

73. Barker SJ, Tremper KK: Advances in oxygen moni-

toring; pulse oximetry: Applications and limitations.

Int Anesthesiol Clin 15:3, 1987.

74. Hoffman RA, Krieger BP, Kramer MR, et al: End-

tidal carbon dioxide in critically ill patients during

changes in mechanical ventilation. Am Rev Respir

Dis 140:1265, 1989.

75. Manaro GA: Protective lung strategies during arti-

ficial ventilation. Eur J Anaesth 15:630, 2005.

76. Leach CL, Greenspan DS, Rubinstein SD, et al:

Partial liquid ventilation with Perflubron in prema-

ture infants with severe respiratory distress syn-

drome. J Pediatr 1117:106, 1997.

77. Westly CR, Cotton EK, Brooks JG: Nebulized

racemic epinephrine by IPPB for the treatment of

croup. Am Dis Child 132:484, 1978.

78. Leipzig B, Oski FA, Cummings CW, et al: A prospec-

tive randomized study to determine the efficacy of

steroids in treatment of croup. J Pediatr 94:194,

1979.

79. Fuglksang G, Pedersen S, Borgstrom L: Dose-res-

ponse relationships of intravenously administered

terbutaline in children with asthma. J Pediatr

114:315, 1989.

80. Shapiro NM: Intracranial hypertension: Therapeutic

and anesthetic considerations. Anesthesiology

43:445, 1975.

81. Kazzi NJ, Brans YW, Poland RL: Dexamethasone

effects on the hospital course of infants with bron-

chopulmonary dysplasia who are dependent on

artificial ventilation. Pediatrics 86:722, 1990.

82. Pascucci RC: Pediatric intensive care.

In

Gregory

GA (ed): Pediatric Anesthesia. New York, Churchill

Livingstone, 1989, p 1316.

83. Bhende BS, LaLovey DC: End-tidal carbon dioxide

monitoring in the prehospital setting. Prehosp

Emerg Care 5:208, 2001.

Cuidados intensivos pediátricos y neonatales

2465

74

Sección V

Anestesia pediátrica

© ELSEVIER. Fotocopiar sin autorización es un delito